These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Prognostic significance of PD-L1 in solid tumor: An updated meta-analysis. Wang Q, Liu F, Liu L. Medicine (Baltimore); 2017 May; 96(18):e6369. PubMed ID: 28471952 [Abstract] [Full Text] [Related]
8. Prognostic and Clinicopathological Value of Programmed Death Ligand-1 in Breast Cancer: A Meta-Analysis. Guo Y, Yu P, Liu Z, Maimaiti Y, Wang S, Yin X, Liu C, Huang T. PLoS One; 2016 May; 11(5):e0156323. PubMed ID: 27227453 [Abstract] [Full Text] [Related]
10. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis. Liu Y, Wu K, Shi L, Xiang F, Tao K, Wang G. PLoS One; 2016 May; 11(11):e0166230. PubMed ID: 27824926 [Abstract] [Full Text] [Related]
12. Prognostic significance of PD-L1 expression in pancreatic cancer: evidence from an updated meta-analysis. Liu C, Fan L, Wu Q, Shi Y, Sun X. Pol J Pathol; 2023 May; 74(3):151-160. PubMed ID: 37955534 [Abstract] [Full Text] [Related]
14. PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups. Schmidt LH, Kümmel A, Görlich D, Mohr M, Bröckling S, Mikesch JH, Grünewald I, Marra A, Schultheis AM, Wardelmann E, Müller-Tidow C, Spieker T, Schliemann C, Berdel WE, Wiewrodt R, Hartmann W. PLoS One; 2015 May; 10(8):e0136023. PubMed ID: 26313362 [Abstract] [Full Text] [Related]
15. The Prognostic and Clinicopathological Roles of PD-L1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis. Li Y, He M, Zhou Y, Yang C, Wei S, Bian X, Christopher O, Xie L. Front Pharmacol; 2019 May; 10():139. PubMed ID: 30873025 [Abstract] [Full Text] [Related]
18. Prognostic significance of microRNA-101 in solid tumor: A meta-analysis. Ma X, Bai J, Xie G, Liu Y, Shuai X, Tao K. PLoS One; 2017 May; 12(7):e0180173. PubMed ID: 28742860 [Abstract] [Full Text] [Related]